Back to results
US 6,958,141 B2Granted
Rhenium and technetium complexes containing a hypoxia-localizing moiety
AssigneeBracco International B.V.
InventorsKaren Linder, Adrian D. Nunn, David P. Nowotnik, Kondareddiar Ramalingam, Richard J. DiRocco, William L. Rumsey, John P. Pirro
Life of this patent
Estimating the term…
Abstract
Novel methods, processes and metal complexes attached to a hypoxia-localizing moiety comprising a metal, preferably radionuclide of rhenium or technetium; a hypoxia-localizing moiety; and, a complexing ligand, wherein said ligand and said radionuclide combined have cell membrane permeabilities greater than that of sucrose, are disclosed.
Claims2
A method of radiotherapy comprisin the step of treating a host with a compound of the formulae complexed with a radionuclide suitable for radiotherapy:
- where at least one R is -(A)p-R2 where (A)p is a linking group and R2 is a nitro-heterocyclic hypoxia localizing moiety;
- and wherein the other R groups are the same, or different and are independently selected from hydrogen, halogen, hydroxy, alkyl, alkenyl, alkynyl, alkoxy, aryl, —COOR3, —(CO)—NHR3, —NH2, hydroxyalkyl, alkoxyalkyl, hydroxyaryl, haloalkyl, arylalkyl, -alkyl-COOR3, -alkyl-CON(R3)2, -alkyl-N(R3)2, -aryl-COOR3, -aryl-CON(R3)2, -aryl-N(R3)2, 5or 6-membered nitrogen- or oxygen-containing heterocycle;
- or two R groups taken together with the one or more atoms to which they are attached form a carbocyclic or heterocyclic, saturated or unsaturated spiro or fused ring which may be substituted with R groups;
- R1 is hydrogen, a thiol protecting group or -(A)p-R2;
- R3 is hydrogen, alkyl or aryl;
- m=2 to 5;
- p=0 to 20.
4 more elements
Dependencies are inferred from the claim text.